In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the latest in drug shortages across the US market, the damaging impact of cybersecurity and ransomware attacks on health systems and hospitals, and the FDA’s approval of Zurzuvae, a depression pill specific to treat severe depression after childbirth. 

Podcast Tags: healthcare, healthcare news, life sciences, public health, drug shortages, cybersecurity, ransomware, FDA, women’s health, reproductive health, post-partum depression, mental health 

Source Links: 

• Pfizer adds rocky mount meds emergency ordering list thwart hospital shortages 
• Drugmakers are abandoning cheap generics and now US cancer patients can’t get meds
• South Dakota Drug Shortage Stockpile
• Hackers force hospital system to take its nation computer system offline 
• Hospitals risk of data breach doubles just before, after a merger deal, research shows
• HHS release free online cybersecurity training, best practice reports for healthcare 
• Hospitals top all industries when it comes to money lost in data breach 
• FDA Approves First Pill for Postpartum Depression 
• FDA Approves first postpartum depression pill in the US  
• Biogen, Sage’s postpartum depression approval overshadowed by larger rejection 
• More US counties have become maternity deserts since 2020 

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC. 

Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector

[email protected]

Ryan Hummel, Executive and Head of Provider Sector

[email protected]

Jen Burke, Director

[email protected]